109 related articles for article (PubMed ID: 15872365)
1. DNA uptake of 131I-iododeoxyuridine.
Baranowska-Kortylewicz J; Nearman J
J Nucl Med; 2005 May; 46(5):898-9. PubMed ID: 15872365
[No Abstract] [Full Text] [Related]
2. Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.
Chi KH; Wang HE; Wang YS; Chou SL; Yu HM; Tseng YH; Hwang IM; Lui WY
J Nucl Med; 2004 Mar; 45(3):478-84. PubMed ID: 15001691
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase and the cell cycle: what should we believe?
Dolnick BJ
Cancer J; 2000; 6(4):215-6. PubMed ID: 11038140
[No Abstract] [Full Text] [Related]
4. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON].
Ou X; Tan T; Li Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-kappaB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell.
Wang HE; Wu HC; Kao SJ; Tseng FW; Wang YS; Yu HM; Chou SL; Yen SH; Chi KH
Biochem Pharmacol; 2005 Feb; 69(4):617-26. PubMed ID: 15670580
[TBL] [Abstract][Full Text] [Related]
7. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
[TBL] [Abstract][Full Text] [Related]
8. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
Humm JL; Bagshawe KD; Sharma SK; Boxer G
Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
[TBL] [Abstract][Full Text] [Related]
9. Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors.
Mester J; DeGoeij K; Sluyser M
Eur J Cancer; 1996 Aug; 32A(9):1603-8. PubMed ID: 8911125
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxins and cancer immunotherapy: the dance of the macabre?
Allegra CJ; Childs RW
J Natl Cancer Inst; 2005 Oct; 97(19):1396-7. PubMed ID: 16204684
[No Abstract] [Full Text] [Related]
11. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer.
Panjideh H; Da Silva Coelho VC; Dernedde J; Bachran C; Förster GJ; Franke J; Fasold P; Fuchs H; Thiel E; Deckert PM
Int J Oncol; 2008 Apr; 32(4):925-30. PubMed ID: 18360720
[TBL] [Abstract][Full Text] [Related]
13. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
[TBL] [Abstract][Full Text] [Related]
14. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of cell subpopulations obtained from a heterogeneous human colon adenocarcinoma to ultraviolet light.
Loeffler J; Eisenberg P; Glicksman AS; Leith JT
Radiat Res; 1983 Oct; 96(1):211-7. PubMed ID: 6622652
[No Abstract] [Full Text] [Related]
16. Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.
Li L; Xu HY; Mi L; Bian HJ; Qin J; Xiong H; Feng Q; Wen N; Tian R; Xu LQ; Shen XM; Tang H; Chen ZN
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1238-44. PubMed ID: 16979831
[TBL] [Abstract][Full Text] [Related]
17. Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and retention.
Palm S; Bäck T; Claesson I; Delle U; Hultborn R; Lindegren S; Jacobsson L
Anticancer Res; 2003; 23(2B):1219-21. PubMed ID: 12820374
[TBL] [Abstract][Full Text] [Related]
18. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimic in H630 colon cancer cells.
Dolnick R; Wu Q; Angelino NJ; Stephanie LV; Chow KC; Sufrin JR; Dolnick BJ
Cancer Res; 2005 Jul; 65(13):5917-24. PubMed ID: 15994970
[TBL] [Abstract][Full Text] [Related]
20. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?
Prall F; Ostwald C; Schiffmann L; Barten M
Oncol Rep; 2007 Jul; 18(1):203-9. PubMed ID: 17549369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
